No Data
No Data
Shareholders Should Be Pleased With TransMedics Group, Inc.'s (NASDAQ:TMDX) Price
When you see that almost half of the companies in the Medical Equipment industry in the United States have price-to-sales ratios (or "P/S") below 3.1x, TransMedics Group, Inc. (NASDAQ:TMDX) looks to
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., July 18, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
Transmedics Group Insider Sold Shares Worth $1,252,051, According to a Recent SEC Filing
Waleed H Hassanein, Director, President & CEO, on July 15, 2024, sold 8,625 shares in Transmedics Group (TMDX) for $1,252,051. Following the Form 4 filing with the SEC, Hassanein has control over a
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
TransMedics (TMDX) Moves to Buy: Rationale Behind the Upgrade
Here's How Much $100 Invested In TransMedics Gr 5 Years Ago Would Be Worth Today
TransMedics Gr (NASDAQ:TMDX) has outperformed the market over the past 5 years by 27.68% on an annualized basis producing an average annual return of 41.28%. Currently, TransMedics Gr has a market
BH_6730 : Fantastic
眼观六路的沃勒 : Like![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d.png)
Master Corgi : Damn you miss out PANW
Dramericanjesus : Being able to read a financial statement is far more valuable.